| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0013227> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0037473> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0037522> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33720607_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Sechenov First Moscow State Medical University (Sechenov University).\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Agadzhanov_V_G> <https://research.tib.eu/covid-19/entity/Bunina_D_V> <https://research.tib.eu/covid-19/entity/Gandybina_E_G> <https://research.tib.eu/covid-19/entity/Khorobrykh_T_V> <https://research.tib.eu/covid-19/entity/Makhnach_G_K> <https://research.tib.eu/covid-19/entity/Mishchenko_N_P> <https://research.tib.eu/covid-19/entity/Svistunov_A_A> <https://research.tib.eu/covid-19/entity/Volgin_M_V>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Terapevticheskii arkhiv
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33720607>
?:pmid	<https://research.tib.eu/covid-19/entity/33720607>
?:pmid	33720607
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.141
?:rankingScore_hIndex	12
?:title	[Administration of the immunomodulatory drug aminodihydrophthalazinedione sodium for prevention of progression pneumonia induced COVID-19].
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33720607>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33720607>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all